Synaptogenix Correlations

SNPX Stock

USD 2.76 0.10 3.50%

The current 90-days correlation between Synaptogenix and Alzamend Neuro is 0.07 (i.e., Significant diversification). The correlation of Synaptogenix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Synaptogenix Correlation With Market

Significant diversification

The correlation between Synaptogenix and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Synaptogenix and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synaptogenix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.

Moving together with Synaptogenix Stock

0.65	ME	23Andme Holding	Pair Corr
0.64	DRMA	Dermata Therapeutics	Pair Corr
0.65	DRTS	Alpha Tau Medical	Pair Corr
0.68	SABSW	SAB Biotherapeutics	Pair Corr
0.73	VRAX	Virax Biolabs Group	Pair Corr
0.74	VTGN	VistaGen Therapeutics	Pair Corr

Moving against Synaptogenix Stock

0.53	DVAX	Dynavax Technologies	Pair Corr
0.42	VALN	Valneva SE ADR	Pair Corr
0.32	VIGL	Vigil Neuroscience	Pair Corr
0.31	DTIL	Precision BioSciences Earnings Call This Week	Pair Corr
0.67	VRTX	Vertex Pharmaceuticals	Pair Corr
0.63	CDTTW	Conduit Pharmaceuticals	Pair Corr
0.52	VTVT	vTv Therapeutics	Pair Corr
0.43	EDIT	Editas Medicine	Pair Corr
0.43	EDSA	Edesa Biotech	Pair Corr
0.33	VRNA	Verona Pharma PLC	Pair Corr

Related Correlations Analysis

	ANVS	CYTH	RVPH	INMB	ALZN
ANVS		-0.41	0.68	-0.62	0.86	ANVS
CYTH	-0.41		-0.01	0.75	-0.11	CYTH
RVPH	0.68	-0.01		-0.2	0.75	RVPH
INMB	-0.62	0.75	-0.2		-0.42	INMB
ALZN	0.86	-0.11	0.75	-0.42		ALZN
	ANVS	CYTH	RVPH	INMB	ALZN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ALZN	+ 0.86	ANVS
INMB	+ 0.75	CYTH
ALZN	+ 0.75	RVPH
RVPH	+ 0.68	ANVS

High negative correlations

INMB	- 0.62	ANVS
ALZN	- 0.42	INMB
CYTH	- 0.41	ANVS
INMB	- 0.2	RVPH
ALZN	- 0.11	CYTH
RVPH	- 0.01	CYTH

Risk-Adjusted Indicators

There is a big difference between Synaptogenix Stock performing well and Synaptogenix Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Synaptogenix's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ANVS	4.36	(1.39)	0.00	(1.02)	0.00	0.00	5.48	(8.63)	45.80
CYTH	4.83	0.32	0.08	(0.57)	5.28	(7.33)	10.29	(10.14)	76.39
RVPH	5.20	(0.55)	0.00	(0.24)	0.00	0.00	11.90	(11.11)	51.04
INMB	4.70	0.67	0.14	0.75	4.63	(5.59)	12.57	(8.23)	28.67
ALZN	3.16	(0.16)	0.00	(0.21)	0.00	0.00	5.00	(7.29)	16.94

Synaptogenix Corporate Executives

Elected by the shareholders, the Synaptogenix's board of directors comprises two types of representatives: Synaptogenix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Synaptogenix. The board's role is to monitor Synaptogenix's management team and ensure that shareholders' interests are well served. Synaptogenix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Synaptogenix's outside directors are responsible for providing unbiased perspectives on the board's policies.

Robert Weinstein

Executive CFO

Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC